TT
Insider
Tolga Tanguler
EVP, Chief Commercial OfficerTolga Tanguler (EVP, Chief Commercial Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Alnylam Pharmaceuticals, Inc. (ALNY). The largest single filing was $607K of ALNY (1,959 sh × $310.08, as filed), executed Feb 13.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.5M
shares × price, as filed
Last traded
Mar 4
Filed Mar 6
Median ADV $470.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
ALNYRecent filings
ALNYSALE
Alnylam Pharmaceuticals, Inc.
View filing →
$361K1,117 sh across 2 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. View filing → $236K
721 sh across 2 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. View filing → $607K
1,959 sh × $310.08
Exec Feb 13
Filed Feb 17 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. View filing → $262K
579 sh across 2 lots
Exec Oct 2 2025
Filed Oct 3 2025 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. View filing → $1.4M
3,135 sh across 4 lots
Exec Aug 29 2025
Filed Sep 2 2025 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. View filing → $505K
1,113 sh across 3 lots
Exec Aug 18 2025
Filed Aug 19 2025 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. View filing → $208K
826 sh × $251.42
Exec Nov 26 2024
Filed Nov 27 2024 · 5:30 PM ET